Search
for
Sort by
Research 121–150 of 1000+
- Janus kinase inhibitors for alopecia areata
- 1325 Age-dependent loss of the stemness and antimicrobial defense function of dermal fibroblasts is mediated by TGFbeta
- Learning from nudity: lessons from the nude phenotype
- The PDGF/PDGFR pathway as a drug target
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- Janus kinase inhibitors for alopecia areata: A narrative review
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- A protein kinase target of a PDK1 signalling pathway is involved in root hair growth in Arabidopsis
- A preliminary study of differentially expressed genes in expanded skin and normal skin: implications for adult skin regeneration
- Induction of versican by ascorbic acid 2-phosphate in dermal papilla cells
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- TGF-β Family Signaling in Epithelial Differentiation and Epithelial–Mesenchymal Transition
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Modern Management Approaches for Alopecia Areata
- Ritlecitinib: First Approval
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection
- New drugs under investigation for the treatment of alopecias
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- A review of Janus kinase inhibitor use in scarring alopecia
- Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events
- Hair Follicle Reconstruction and Stem Cells
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique